BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26867712)

  • 1. Inhaled Mannitol (Bronchitol) for Cystic Fibrosis.
    Nolan SJ; Thornton J; Murray CS; Dwyer T
    Paediatr Respir Rev; 2016 Mar; 18():52-4. PubMed ID: 26867712
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhaled mannitol in patients with cystic fibrosis: A randomised open-label dose response trial.
    Teper A; Jaques A; Charlton B
    J Cyst Fibros; 2011 Jan; 10(1):1-8. PubMed ID: 20888307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hitting the target: new treatments for cystic fibrosis.
    Davis SD; Ferkol TW
    Am J Respir Crit Care Med; 2010 Dec; 182(12):1460-1. PubMed ID: 21159902
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhaled mannitol (Bronchitol) for cystic fibrosis.
    Med Lett Drugs Ther; 2021 May; 63(1625):85-86. PubMed ID: 34101719
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhaled mannitol improves lung function in cystic fibrosis.
    Jaques A; Daviskas E; Turton JA; McKay K; Cooper P; Stirling RG; Robertson CF; Bye PTP; LeSouëf PN; Shadbolt B; Anderson SD; Charlton B
    Chest; 2008 Jun; 133(6):1388-1396. PubMed ID: 18339790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term inhaled dry powder mannitol in cystic fibrosis: an international randomized study.
    Aitken ML; Bellon G; De Boeck K; Flume PA; Fox HG; Geller DE; Haarman EG; Hebestreit HU; Lapey A; Schou IM; Zuckerman JB; Charlton B;
    Am J Respir Crit Care Med; 2012 Mar; 185(6):645-52. PubMed ID: 22198974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled mannitol for the treatment of cystic fibrosis.
    Hurt K; Bilton D
    Expert Rev Respir Med; 2012 Feb; 6(1):19-26. PubMed ID: 22283575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost Effectiveness of Inhaled Mannitol (Bronchitol
    Warren E; Morgan K; Toward TJ; Schwenkglenks M; Leadbetter J
    Pharmacoeconomics; 2019 Mar; 37(3):435-446. PubMed ID: 30666534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Non-cystic fibrosis bronchiectasis [corrected]].
    Ringshausen FC; Rademacher J; Welte T
    Dtsch Med Wochenschr; 2014 Apr; 139(14):707-10. PubMed ID: 24668431
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dry powder inhalers in cystic fibrosis].
    Steinkamp G
    Pneumologie; 2014 Jun; 68(6):378-85. PubMed ID: 24664997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NICE guidance on inhaled mannitol for treatment of cystic fibrosis.
    Jennings G; Jonsson PF; George E; Adler AI
    Lancet Respir Med; 2013 Mar; 1(1):e19-20. PubMed ID: 24321814
    [No Abstract]   [Full Text] [Related]  

  • 12. Question 3: Inhaled mannitol improves lung function in patients with cystic fibrosis.
    Winckworth LC; Holme H
    Arch Dis Child; 2012 Nov; 97(11):1003-6. PubMed ID: 23100616
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhaled mannitol and cystic fibrosis. Unnecessary bronchial irritation.
    Prescrire Int; 2014 Apr; 23(148):89-91. PubMed ID: 24860889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of inhaled dry-powder mannitol during cystic fibrosis-related pulmonary exacerbation.
    Middleton A; Robinson PD; McKay K; Jaffe A; Selvadurai H
    Eur Respir J; 2015 Feb; 45(2):541-4. PubMed ID: 25359334
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of inhaled dry powder mannitol on mucus and its clearance.
    Daviskas E; Rubin BK
    Expert Rev Respir Med; 2013 Feb; 7(1):65-75. PubMed ID: 23362816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety and feasibility of the inhaled mannitol challenge test in young children.
    Alblooshi AS; Simpson SJ; Stick SM; Hall GL
    Eur Respir J; 2013 Nov; 42(5):1420-3. PubMed ID: 23988769
    [No Abstract]   [Full Text] [Related]  

  • 17. Repurposing excipients as active inhalation agents: The mannitol story.
    Anderson SD; Daviskas E; Brannan JD; Chan HK
    Adv Drug Deliv Rev; 2018 Aug; 133():45-56. PubMed ID: 29626547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pooled analysis of two large randomised phase III inhaled mannitol studies in cystic fibrosis.
    Bilton D; Bellon G; Charlton B; Cooper P; De Boeck K; Flume PA; Fox HG; Gallagher CG; Geller DE; Haarman EG; Hebestreit HU; Kolbe J; Lapey A; Robinson P; Wu J; Zuckerman JB; Aitken ML;
    J Cyst Fibros; 2013 Jul; 12(4):367-76. PubMed ID: 23234802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled dry powder mannitol: a solution for cystic fibrosis.
    Trapnell BC
    Am J Respir Crit Care Med; 2012 Mar; 185(6):596-8. PubMed ID: 22422901
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.
    Bilton D; Tino G; Barker AF; Chambers DC; De Soyza A; Dupont LJ; O'Dochartaigh C; van Haren EH; Vidal LO; Welte T; Fox HG; Wu J; Charlton B;
    Thorax; 2014 Dec; 69(12):1073-9. PubMed ID: 25246664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.